Abstract
Diabetes mellitus is a disorder in which blood sugar (glucose) levels are abnormally high because the body does not produce enough insulin to meet its needs. Post-prandial hyperglycemia (PPHG) is an independent risk factor for the development of macro vascular complications. It is now recognized that normalizing post-prandial blood glucose is more difficult than normalizing fasting glucose. Potassium channels are the most widely distributed type of ion channel and are found in virtually all living organisms. The function of KATP channels is best understood in pancreatic beta cells, the membrane potential of which is responsive to external glucose concentration. Beta cells show a remarkably complex electrical bursting behavior in response to an increase in glucose level. Nateglinide and Glimepiride are a class of insulin secretagog agents that lowers blood glucose levels by stimulating insulin secretion from the pancreas. These compounds interact with the ATP-sensitive potassium (K+ATP) channel in pancreatic beta cells. However, the side effects of these drugs overpass their uses, and the need to identify compounds with less adverse effects is exigent. In our research study, we used the natural compound ellagic acid, which is an already proven anti-carcinogen, anti-mutagen, and anticancer initiator, for its anti-diabetic activity in comparison to the two commercial drugs (Nateglinide and Glimepiride). The drugs and the compounds were docked to the ATP-dependent potassium channel and their energy value showed that the compound had higher binding value than the commercial drugs. Then an ADME/Tox analysis for the compound was carried out which showed that ellagic can be a possible lead molecule.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
L. Aguilar-Bryan, J. Bryan. Molecular biology of adenosine triphosphate-sensitive potassium channels. Endocr. Rev. 20(2):101–135
D.-.K. Song, M. Fances. Ashcroft,,Glimepiride block of cloned b-cell, cardiac and smooth muscle katp channels. Br. J. Pharmacol. 133:193–199, 2001.
M. Chachin, M. Vamada, A. Fujita, T. Matsuoka, K. Matsushita, Y. Kurachi. Nateglinide, a d-phenylalanine derivative lacking either a sulfonylurea or benzamido moiety, specifically inhibits pancreatic – cell-type katp channels. J Pharmacol. Exp. Ther. 304(3)
H. S. Aiyer, M. V. Vadhanam, R. Stoyanova, G.D. Caprio, M. L. Clapper, R. C. Gupta. Dietary berries and ellagic acid prevent oxidative dna damage and modulate expression of dna repair genes. Int. J. Mol. Sci. 9:327–341, 2008.
N. Eswar, M. A. Marti-renom, B. Webb, M. S. Madhusudhan, D. Eramian, M. Shen, U. Pieper, A. Sali. Comparative protein structure modeling with modeller. Current protocols in bioinformatics. Wiley, New York, supplement 15, 5.6.1–5.6.30, 2006.
M. A. Marti-renom, A. Stuart, A. Fiser, R. Sánchez, F. Melo, A. Sali. Comparative protein structure modeling of genes and genomes. Annu. Rev. Biophys. Biomol. Struct. 29:291–325, 2000.
A. Sali, T. L. Blundell. Comparative protein modelling by satisfaction of spatial restraints. J. Mol. Biol. 234:779–815, 1993.
A. Fiser, R. K. Do, A. Sali. Modeling of loops in protein structures. Protein Sci 9:1753–1773, 2000.
Guillaume launay and thomas simonson. Homology modelling of protein-protein complexes: a simple method and its possibilities and limitations. BMC Bioinformatics 9:427, 2008.
R. A. Laskowski, M. W. Macarthur, D. S. Moss, J. M. Thornton Procheck: a program to check the stereochemical quality of protein structures. J. Appl. Cryst. 26:283–291, 1993.
A. L. Morris, M. W. Macarthur, E. G. Hutchinson, J. M. Thornton. Stereo chemical quality of protein structure coordinates. Proteins 12:345–364, 1992.
Ilya n.shindyalov,philip e.bourne.protein structural alignment by incremental combinatorial extension(ce) of the optimal path. Protein Eng. 11(9):739–7747, 1998.
Sérgio filipe sousa, pedro alexandrino fernandes, maria joão ramos.protein-ligand docking: current status and future challenges.
G. M. Morris, D. S. Goodsell, R. S. Halliday 2, R. Huey, W. E. Hart, R. K. Belew, J. Arthur. Olson Automated docking using a lamarckian genetic algorithm and an empirical binding free energy function.
S. K. Lee, I. H. Lee, H. J. Kim, G. S. Chang, J. E. Chung, K. T. No. The PreADME Approach: Web-based program for rapid prediction of physico-chemical, drug absorption and drug-like properties. EuroQSAR 2002 Designing drugs and crop protectants: processes, problems and solutions. Blackwell Publishing, Boston, MA, pp. 418–420, 2003.
T. Alasdair, R. Laurie, R. M. Jackson. Q-SiteFinder: an energy-based method for the prediction of protein–ligand binding sites
S. Miret et al. Comparison of in vitro models for the prediction of compound absorption across the human intestinal mucosa. J. Biomol. Screen. 9(7):598–606, 2004, DOI: 10.1177/1087057104267162.
C. A. Lipinski et al., Adv. Drug Del. Rev. 23:3, 1997, [PMID:11259830].
B. N. Ames, E. G. Gurney, J. A. Miller, H. Artsch. Carcinogens as frameshift mutagens: metabolites and derivatives of 2-acetylaminofluorene and other aromatic amine carcinogens (aromatic nitroso carcinogens/carcinogen detection with Salmonella/DNA intercalation)”, Proc. Natl. Acad. Sci. USA 69(11):3128–3132.
M. Tasaki, T. Umemura, M. Maeda, Y. Ishii, T. Okamura, T. Inoue, Y. Kuroiwa, M. Hirose, A. Nishikawa. Safety assessment of ellagic acid, a food additive, in a subchronic toxicity study using F344 rats. Food Chem. Toxicol. 46(3):1119–24, 2008.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media, LLC
About this paper
Cite this paper
Mathew, A.J., Raj, N.N., Sugappriya, M., Priyadarshini, S.M. (2010). Modeling of ATP-Sensitive Inward Rectifier Potassium Channel 11 and Inhibition Mechanism of the Natural Ligand, Ellagic Acid, Using Molecular Docking. In: Arabnia, H. (eds) Advances in Computational Biology. Advances in Experimental Medicine and Biology, vol 680. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-5913-3_55
Download citation
DOI: https://doi.org/10.1007/978-1-4419-5913-3_55
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-5912-6
Online ISBN: 978-1-4419-5913-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)